Evidence map›Paper›PMID 26110041›Full record

ArticleBiochemia medica2015

A case report of short-chain acyl-CoA dehydrogenase deficiency (SCADD).

Barbka Repic Lampret, Simona Murko, Marusa Debeljak, Mojca Zerjav Tansek, Petja Fister, Tadej Battelino

Abstract readCase Reports
In one paragraph

Article in Biochemia medica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Barbka Repic LampretUniversity Medical Centre Ljubljana, University Children's Hospital, Ljubljana, Slovenia.
Simona MurkoUniversity Medical Centre Ljubljana, University Children's Hospital, Ljubljana, Slovenia.
Marusa DebeljakUniversity Medical Centre Ljubljana, University Children's Hospital, Ljubljana, Slovenia.
Mojca Zerjav TansekUniversity Medical Centre Ljubljana, University Children's Hospital, Ljubljana, Slovenia.
Petja FisterUniversity Medical Centre Ljubljana, University Children's Hospital, Ljubljana, Slovenia.
Tadej BattelinoUniversity Medical Centre Ljubljana, University Children's Hospital, Ljubljana, Slovenia ; University of Ljubljana, Faculty of Medicine, Department of Paediatrics, Ljubljana, Slovenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundShort-chain acyl-CoA dehydrogenase deficiency (SCADD) is a rare inherited mitochondrial fatty acid oxidation disorder associated with variations in the ACADS (Acyl-CoA dehydrogenase, C-2 to C-3 short chain) gene. SCADD has highly variable biochemical, genetic and clinical characteristics. Phenotypes vary from fatal metabolic decompensation to asymptomatic individuals. SUBJECT AND

methodsA Romani boy presented at 3 days after birth with hypoglycaemia, hypotonia and respiratory pauses with brief generalized seizures. Afterwards the failure to thrive and developmental delay were present. Organic acids analysis with gas chromatography-mass spectrometry (GS/MS) in urine and acylcarnitines analysis with liquid chromatography-tandem mass spectrometry (LC-MS/MS) in dried blood spot were measured. Deoxyribonucleic acid (DNA) was isolated from blood and polymerase chain reactions (PCRs) were performed for all exons. Sequence analysis of all exons and flanking intron sequences of ACADS gene was performed.

resultsOrganic acids analysis revealed increased concentration of ethylmalonic acid. Acylcarnitines analysis showed increase of butyrylcarnitine, C4-carnitine. C4-carnitine was 3.5 times above the reference range (<0.68 µmol/L). Confirmation analysis for organic acids and acylcarnitine profile was performed on the second independent sample and showed the same pattern of increased metabolites. Sequence analysis revealed 3-bp deletion at position 310-312 in homozygous state (c.310_312delGAG). Mutation was previously described as pathogenic in heterozygous state, while it is in homozygous state in our patient.

conclusionsIn our case clinical features of a patient, biochemical parameters and genetic data were consistent and showed definitely SCAD deficiency.

Indexed as

Base SequenceSequence Deletion3-Hydroxyacyl CoA DehydrogenasesAcyl-CoA DehydrogenaseDNA Mutational AnalysisHumansInfantLipid Metabolism, Inborn ErrorsMalePolymerase Chain Reaction3-Hydroxyacyl CoA DehydrogenasesAcyl-CoA Dehydrogenaseacylcarnitinepolymorphism, geneticSCAD deficiencyscreeningshort chain acyl-CoA dehydrogenase deficiency

Identifiers

PMID26110041
PMCPMC4470102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.